iSpecimen (NASDAQ:ISPC – Get Rating) is one of 41 publicly-traded companies in the “Commercial physical research” industry, but how does it contrast to its competitors? We will compare iSpecimen to related businesses based on the strength of its dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation. Valuation and Earnings This table compares iSpecimen […]